Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada.
Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada
Drug Metab Dispos. 2017 Oct;45(10):1077-1083. doi: 10.1124/dmd.117.076927. Epub 2017 Aug 4.
Endotoxin-induced inflammation decreases the hepatic expression of several drug transporters, metabolizing enzymes, and nuclear transcription factors, including pregnane X receptor (PXR). As the nuclear factor B (NF-B) is a major mediator of inflammation, and reciprocal repression between NF-B and PXR signaling has been reported, the objective of this study was to examine whether NF-B directly regulates the expression of transporters or exerts its effect indirectly via PXR. PXR-deficient (-/-) or wild-type (+/+) male mice were dosed with the selective NF-B inhibitor PHA408 (40 mg/kg i.p.) or vehicle ( = 5-8/group), followed by endotoxin (5 mg/kg) or saline 30 minutes later. Animals were sacrificed at 6 hours; samples were analyzed using quantitative reverse-transcription polymerase chain reaction and Western blots. Endotoxin induced tumor necrosis factor-, interleukin (IL)-6, IL-1, and inducible nitric oxide synthase in PXR (+/+) and (-/-) mice. As compared with saline controls, endotoxin administration imposed 30%-70% significant decreases in the expression of Abcb1a, Abcb11, Abcc2, Abcc3, Abcg2, Slc10a1, Slco2b1, and Slco1a4 in PXR (+/+) and (-/-) mice to a similar extent. Preadministration of PHA408 attenuated endotoxin-mediated changes in both PXR (+/+) and (-/-) mice ( < 0.05). Our findings demonstrate that endotoxin activates NF-B and imposes a downregulation of numerous ATP-binding cassette and solute carrier transporters through NF-B in liver and is independent of PXR. Moreover, inhibition of NF-B attenuates the impact of endotoxin on transporter expression. As NF-B activation is involved in many acute and chronic disease states, disease-induced changes in transporter function may be an important source of variability in drug response. This information may be useful in predicting potential drug-disease interactions.
内毒素诱导的炎症会降低几种药物转运体、代谢酶和核转录因子的肝表达,包括孕烷 X 受体 (PXR)。由于核因子 B (NF-B) 是炎症的主要介质,并且已经报道了 NF-B 和 PXR 信号之间的相互抑制,本研究的目的是检查 NF-B 是否直接调节转运体的表达,或者是否通过 PXR 发挥其作用。用选择性 NF-B 抑制剂 PHA408(40mg/kg 腹腔注射)或载体(每组 5-8 只)处理 PXR 缺陷型(-/-)或野生型(+/+)雄性小鼠,30 分钟后给予内毒素(5mg/kg)或生理盐水。在 6 小时处死动物;使用定量逆转录聚合酶链反应和 Western 印迹分析样品。内毒素诱导 PXR(+/+)和(-/-)小鼠肿瘤坏死因子-α、白细胞介素(IL)-6、IL-1 和诱导型一氧化氮合酶的表达。与生理盐水对照相比,内毒素给药导致 PXR(+/+)和(-/-)小鼠中 Abcb1a、Abcb11、Abcc2、Abcc3、Abcg2、Slc10a1、Slco2b1 和 Slco1a4 的表达分别显著降低 30%-70%,幅度相似。PHA408 的预先给药减弱了内毒素对 PXR(+/+)和(-/-)小鼠的调节作用(<0.05)。我们的研究结果表明,内毒素激活 NF-B,并通过 NF-B 在肝脏中下调许多 ATP 结合盒和溶质载体转运体,与 PXR 无关。此外,NF-B 抑制减弱了内毒素对转运体表达的影响。由于 NF-B 激活参与许多急性和慢性疾病状态,因此疾病引起的转运体功能变化可能是药物反应变异性的重要来源。这些信息可能有助于预测潜在的药物-疾病相互作用。